Spots Global Cancer Trial Database for chemotherapy drug
Every month we try and update this database with for chemotherapy drug cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer | NCT05798845 | NSCLC | SBRT+LDRT Toripalimab Chemotherapy dr... Toripalimab | 18 Years - 75 Years | Shanghai Chest Hospital | |
| RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma | NCT05028439 | Cholangiocarcin... | radiofrequency ... Chemotherapy dr... | 18 Years - 75 Years | First People's Hospital of Hangzhou | |
| CIETAI and Sequential Radiotherapy in Squamous Lung Cancer | NCT05892237 | Carcinoma, Non-... | bronchial arter... Chemotherapy dr... IMRT Immunotherapy | 18 Years - 80 Years | Third Military Medical University | |
| Carbon Ion RT for Locally Advanced Pancreatic Cancer | NCT04592861 | Pancreatic Canc... | carbon ion RT Chemotherapy dr... | 18 Years - | Albert Einstein College of Medicine | |
| Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment. | NCT06326086 | Advanced Lung C... Sarcopenia | Chemotherapy dr... Targeted Agent Immunotherapy | 18 Years - | Prince of Songkla University | |
| Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment. | NCT06326086 | Advanced Lung C... Sarcopenia | Chemotherapy dr... Targeted Agent Immunotherapy | 18 Years - | Prince of Songkla University | |
| Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model | NCT05289076 | Colorectal Canc... Tumour Metastas... Chemotherapy Ef... Tumor Growth | Chemotherapy dr... | 18 Years - | University Hospital, Linkoeping | |
| Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM | NCT05009446 | Mucosal Melanom... Sinonasal Melan... | endoscopic surg... intensity-modul... Chemotherapy dr... | 18 Years - | Eye & ENT Hospital of Fudan University | |
| Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting | NCT06081400 | Desmoid Tumor | Cryoablation Chemotherapy dr... | 13 Years - | University Hospital, Strasbourg, France | |
| Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients | NCT05755581 | Female Breast C... | Hormonal Antine... Chemotherapy dr... | 18 Years - | Sohag University | |
| A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients | NCT05787613 | NSCLC Stage IV | HLX26 Serplulimab Chemotherapy dr... Placebo | 18 Years - 75 Years | Shanghai Henlius Biotech | |
| RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma | NCT02964260 | Hepatocellular ... | Chemotherapy dr... Embolic agents Simultaneously Sequentially Ablation | 18 Years - 70 Years | Sun Yat-sen University | |
| Olaparib Maintenance Therapy in Metastatic Breast Cancer | NCT05629429 | Metastatic Brea... | Olaparib Chemotherapy dr... | 20 Years - | National Taiwan University Hospital | |
| Carbon Ion RT for Locally Advanced Pancreatic Cancer | NCT04592861 | Pancreatic Canc... | carbon ion RT Chemotherapy dr... | 18 Years - | Albert Einstein College of Medicine | |
| Olaparib Maintenance Therapy in Metastatic Breast Cancer | NCT05629429 | Metastatic Brea... | Olaparib Chemotherapy dr... | 20 Years - | National Taiwan University Hospital | |
| Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer | NCT04483076 | Gastric Cancer Chemotherapy Ef... | Chemotherapy dr... Gastrectomy Laparoscopic ex... | 18 Years - 70 Years | Chinese PLA General Hospital | |
| RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma | NCT05028439 | Cholangiocarcin... | radiofrequency ... Chemotherapy dr... | 18 Years - 75 Years | First People's Hospital of Hangzhou | |
| Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients | NCT05755581 | Female Breast C... | Hormonal Antine... Chemotherapy dr... | 18 Years - | Sohag University | |
| MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. | NCT05255471 | Ovarian Cancer | Olaparib Chemotherapy dr... | 18 Years - | National Cancer Institute, Naples | |
| Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer | NCT05573373 | Carcinoma, Non-... EGF-R Positive ... | Parimparib Chemotherapy dr... Targeted Therap... | 18 Years - | Affiliated Hospital of Jiangnan University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
